Global Large Volume Parenteral Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2023 –2030 |
 Market Size (Base Year) |
USD 9,200.00 Million |
 Market Size (Forecast Year) |
USD 14,998.71 Million |
 CAGR |
% |
| Major Markets Players |
>全球大容量肠外注射市场，按类型（软袋 LVP、塑料瓶 LVP、玻璃瓶 LVP）、容量（100 ml-250 ml、250 ml-500 ml、500 ml-1000 ml、1000 ml-2000 ml、2000 ml 及以上）、应用（治疗注射、液体平衡注射、营养注射）、最终用户（诊所、医院、其他）、分销渠道（医院药房、零售药房、网上药房）划分 - 行业趋势和预测到 2030 年。
大容量肠外市场分析和规模
由于监管要求，全球大容量肠外市场正在稳步增长。不断增长的研发活动极大地推动了全球大容量肠外市场的发展。主要市场参与者的战略举措是推动市场快速增长的因素之一。市场参与者正在扩大其产品供应以获得竞争优势。
Data Bridge Market Research 分析，全球大容量肠外注射市场在 2022 年为 92 亿美元，到 2030 年将飙升至 149.9871 亿美元，预计在预测期内的复合年增长率为 6.3%。由于医疗保健投资不断增加，“软袋”在全球大容量肠外注射市场类型细分市场中占据主导地位。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的洞察外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、渠道分析、定价分析和监管框架。
大容量肠外注射市场范围和细分
|
报告指标 |
细节 |
|
预测期 |
2023 至 2030 年 |
|
基准年 |
2022 |
|
历史岁月 |
2021 (可定制为 2015-2020) |
|
定量单位 |
收入（百万美元）、销量（单位）、定价（美元） |
|
涵盖的领域 |
类型（软袋 LVP、塑料瓶 LVP、玻璃瓶 LVP）、容量（100 ml-250 ml、250 ml-500 ml、500 ml-1000 ml、1000 ml-2000 ml、2000 ml 等）、用途（治疗注射剂、液体平衡注射剂、营养注射剂）、最终用户（诊所、医院、其他）、分销渠道（医院药房、零售药房、网上药房） |
|
覆盖国家 |
美国、加拿大、墨西哥、巴西、阿根廷、秘鲁、南美洲其他地区、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、匈牙利、立陶宛、奥地利、爱尔兰、挪威、波兰、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、越南、亚太其他地区、沙特阿拉伯、阿联酋、埃及、以色列、科威特、南非、中东和非洲其他地区 |
|
涵盖的市场参与者 |
Teva Pharmaceutical Industries Ltd. (Israel), Pfizer Inc. (U.S.), Otsuka America Pharmaceutical, Inc. (U.S.), Sichuan KELUN PHARMACEUTICAL Co., Ltd.(China), Cook Pharmica LLC.(U.S.), Thermo Fisher Scientific Inc. (U.S.), BAG Health Care GmbH (Germany), Baxter (U.S.), WOCKHARDT (India), Southwest Pharmaceutical Co. Ltd. (China) |
|
Market Opportunities |
|
Market Definition
The global Large Volume Parenteral (LVP) market is for intravenous solutions or fluids administered in large volumes to patients. LVPs are sterile solutions typically provided in containers such as bottles or bags. These solutions are used for various medical purposes, including fluid and electrolyte replacement, nutritional support, medication administration, and other therapeutic interventions.
Global Large Volume Parenteral Market Dynamics
Drivers
- Increasing prevalence of chronic diseases
The rising incidence of chronic diseases such as cancer, diabetes, and cardiovascular disorders has led to a growing demand for LVP products, often used for administering medications in these conditions.
- Technological advancements
The development of innovative manufacturing techniques, such as aseptic filling systems and advanced filtration technologies, has improved the safety, sterility, and efficiency of LVP production. These technological advancements have boosted market growth.
Opportunities
-
Expansion of home healthcare
The trend towards home-based healthcare services provides opportunities for the LVP market. Patients receiving long-term intravenous therapies may opt for home healthcare, increasing the demand for LVP products outside traditional hospital settings.
Furthermore, the rising collaboration, merger, and acquisition among the market players will extend profitable opportunities for the market players in the forecast period of 2023 to 2030. In addition, the rising number of market players will further expand the market's growth rate in the future.
Restraint/Challenge
- High cost associated with the product manufacturing
The high cost associated with product manufacturing is expected to obstruct market growth. Also, the supply chain industry disruption can challenge the market's growth. In addition, the lack of a favorable reimbursement scenario, technology penetration in the developing economies, and lack of suitable infrastructure are projected to challenge the market in the forecast period of 2023-2030.
This global large volume parenteral report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global large volume parenteral market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In 2021, Baxter International Inc. received U.S. Food and Drug Administration (FDA) approval for its premixed, ready-to-use 0.9% Sodium Chloride Injection Bags. This product launch aimed to provide healthcare professionals with a convenient option for intravenous fluid therapy.
- In 2020, Pfizer Inc. launched a new presentation of its Liposyn III 30% (Intravenous Fat Emulsion) product. The new presentation offered a larger container size, allowing for easier handling and administration in critical care settings.
Global Large Volume Parenteral Market Scope
The global large volume parenteral market is segmented based on type, volume, application, end-users, and distribution channel. The growth amongst these segments will help you analyse meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Soft Bag LVP
- Plastic Bottle LVP
- Glass Bottle LVP
Volume
- 100 ml-250 ml
- 250 ml-500 ml
- 500 ml-1000 ml
- 1000 ml-2000 ml
- 2000 ml and more
Application
- Therapeutic Injections
- Fluid Balance Injections
- Nutritious Injections
End-Users
- Clinic
- Hospital
- Others
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Global Large Volume Parenteral Market Regional Analysis/Insights
Global large volume parenteral market is analyzed, and market size insights and trends are provided by type, volume, application, end-users, and distribution channel, as referenced above.
The countries covered in the global large volume parenteral market report are U.S., Canada, Mexico, Brazil, Argentina, Peru, rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, and rest of Middle East and Africa.
North America dominates the market due to rising healthcare costs, increased R&D, and trending technological advancements.
由于主要市场参与者不断采取战略举措以及该地区政府采取有利举措，预计亚太地区将在 2023 年至 2030 年的预测期内见证最快的增长。
报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和市场监管变化。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测各个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了欧洲品牌的存在和可用性以及它们因来自本地和国内品牌的大量或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
医疗保健基础设施增长安装基础和新技术渗透
大容量肠外市场还为您提供每个国家/地区资本设备医疗支出增长、大容量肠外市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗监管情景的变化及其对市场的影响的详细市场分析。数据涵盖 2015-2020 年的历史时期。
竞争格局和大宗肠外药物市场份额分析
大容量肠外市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对市场的关注有关。
大容量肠外药物市场的一些主要参与者包括：
- Teva Pharmaceutical Industries Ltd.（以色列）
- 辉瑞公司（美国）
- 大冢美国制药公司（美国）
- 四川科伦药业股份有限公司（中国）
- Cook Pharmica LLC.（美国）
- 赛默飞世尔科技公司（美国）
- BAG Health Care GmbH（德国）
- 百特（美国）
- WOCKHARDT（印度）
- 西南制药股份有限公司 (中国)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
